UC San Diego Moores Cancer Center-Investigational Drug Services is a clinical research site located in La Jolla, California, United States 92037.
Crixeo Clinical Trials Trust Score: 16/100 (FAILING). This profile has not yet been claimed by the site owner.
UC San Diego Moores Cancer Center-Investigational Drug Services has participated in 8 clinical trials with 1 currently active.
Therapeutic areas: Non Small Cell Lung Cancer (NSCLC), ALK-positive Advanced NSCLC, Primary Myelofibrosis; Post-polycythemia Vera Myelofibrosis; Post-essential Thrombocythemia Myelofibrosis.
Sponsors: Pfizer, Seagen, a wholly owned subsidiary of Pfizer.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in California · View every site in La Jolla
Trust Score: 16/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
UC San Diego Moores Cancer Center-Investigational Drug Services has a Crixeo Trust Score of 16/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
UC San Diego Moores Cancer Center-Investigational Drug Services has 8 clinical trials on record, with 1 currently active. Their work covers Non Small Cell Lung Cancer (NSCLC), ALK-positive Advanced NSCLC, Primary Myelofibrosis; Post-polycythemia Vera Myelofibrosis; Post-essential Thrombocythemia Myelofibrosis.
UC San Diego Moores Cancer Center-Investigational Drug Services has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.